High materiality8/10
B.Riley Upgrades Capricor Therapeutics (CAPR) to Buy
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
CAPR received an analyst target update from B.Riley Financial, with a new target of $21 on a current price of $8.37.
- B.Riley raises CAPR target to $21; current price $8.37.
Key facts
- 01
Target: $21
- 02
Posted price: $8.37
- 03
Analyst firm: B.Riley Financial
- 04
Analyst: Madison El-Saadi
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.